selenocysteine and naphthoquinones

selenocysteine has been researched along with naphthoquinones in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Anestål, K; Arnér, ES; Cenas, N; Prast-Nielsen, S1
Arnér, ES; Cheng, Q; Lindqvist, Y; Sandalova, T1
Arnér, ES; Cheng, Q; Xu, J1
Arner, ES; Bertrand, HC; Chen, W; Cheng, Q; Chew, EH; Kaminska, KK; Stafford, WC; Tajima, H; Wells, G1
Guo, J; Ma, K; Ma, Q; Sun, S; Xu, J; Xu, W; Yang, R; Yang, Y; Zhang, J; Zhang, Y1

Other Studies

5 other study(ies) available for selenocysteine and naphthoquinones

ArticleYear
Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.
    PloS one, 2008, Apr-02, Volume: 3, Issue:4

    Topics: Animals; Apoptosis; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Enzyme Inhibitors; HeLa Cells; Humans; Naphthoquinones; Oxidants; Protein Structure, Tertiary; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin-Disulfide Reductase

2008
Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
    The Journal of biological chemistry, 2009, Feb-06, Volume: 284, Issue:6

    Topics: Amino Acid Motifs; Amino Acid Substitution; Animals; Catalysis; Catalytic Domain; Crystallography, X-Ray; Electron Transport; Mutation, Missense; Naphthoquinones; Protein Structure, Tertiary; Rats; Recombinant Proteins; Selenocysteine; Selenoproteins; Structure-Activity Relationship; Thioredoxin Reductase 1; Thioredoxins

2009
Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Free radical biology & medicine, 2016, Volume: 94

    Topics: Amino Acids; Catalysis; Cysteine; Humans; Mutation; NADPH Oxidases; Naphthoquinones; Oxidation-Reduction; Point Mutation; Selenocysteine; Substrate Specificity; Superoxides; Thioredoxin Reductase 1

2016
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
    Oncotarget, 2016, Jun-28, Volume: 7, Issue:26

    Topics: Animals; Antineoplastic Agents; Antioxidants; Catalytic Domain; Cattle; Drug Design; Drug Screening Assays, Antitumor; Fibroblasts; Glutathione Peroxidase; Glutathione Reductase; HCT116 Cells; Humans; Indoles; Inhibitory Concentration 50; MCF-7 Cells; Mice; Naphthoquinones; Oxidative Stress; Protein Domains; Rats; Reactive Oxygen Species; Recombinant Proteins; Selenocysteine; Thioredoxin-Disulfide Reductase; Thioredoxins

2016
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 146

    Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Glucose Transporter Type 1; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Naphthoquinones; NF-E2-Related Factor 2; Pyrazoles; Quinolines; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin Reductase 1

2022